Asymmetric dimethylarginine and coronary collateral vessel development


Kocaman S. A. , ŞAHİNARSLAN A. , BİBEROĞLU G. , Hasanoglu A., Akyel A., Timurkaynak T., ...Daha Fazla

CORONARY ARTERY DISEASE, cilt.19, ss.469-474, 2008 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 19 Konu: 7
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1097/mca.0b013e328311d32b
  • Dergi Adı: CORONARY ARTERY DISEASE
  • Sayfa Sayıları: ss.469-474

Özet

Introduction Nitric oxide (NO) plays a major role in collateral vessel development. Asymmetric dimethylarginine (ADMA) that is an endogenous inhibitor of NO synthesis may impair the effective coronary collateral vessel development. The aim of this study was to evaluate the relationship between plasma ADMA level and coronary collateral vessel development.